Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB- IVA mycosis fungoides/Sézary syndrome.
Saved in:
| Title: | Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB- IVA mycosis fungoides/Sézary syndrome. |
|---|---|
| Authors: | Child, F.1, Ortiz ‐ Romero, P.L.2, Alvarez, R.3, Bagot, M.4, Stadler, R.5, WeichENthal, M.6, Alves, R.7, Quaglino, P.8, Beylot ‐ Barry, M.9, Cowan, R.10, Geskin, L.J.11, Pérez ‐ Ferriols, A.12, Hellemans, P.13, Elsayed, Y.14, Phelps, C.14, Forslund, A.15, Kamida, M.16, Zinzani, P.L.17 |
| Source: | British Journal of Dermatology. Jul2016, Vol. 175 Issue 1, p80-88. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
